{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:58:34Z","timestamp":1791053914522,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":532,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ccr.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T09:17:36Z","timestamp":1329124656000},"page":"212-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"title":["TEM8\/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types"],"prefix":"10.1016","volume":"21","author":[{"given":"Amit","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary\u00a0Beth","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana\u00a0C.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter\u00a0K.","family":"Lemotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William\u00a0R.","family":"Tschantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan\u00a0M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"St.\u00a0Croix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2012.01.004_bib1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2217\/fon.10.122","article-title":"ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy","volume":"6","author":"Baguley","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.ccr.2012.01.004_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2012.01.004_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11523-010-0158-1","article-title":"Vascular endothelial growth factor inhibitors in malignant gliomas","volume":"5","author":"Brastianos","year":"2010","journal-title":"Target. Oncol."},{"key":"10.1016\/j.ccr.2012.01.004_bib4","first-page":"6649","article-title":"Cell surface tumor endothelial markers are conserved in mice and humans","volume":"61","author":"Carson-Walter","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2012.01.004_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","article-title":"Adverse effects of anticancer agents that target the VEGF pathway","volume":"6","author":"Chen","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccr.2012.01.004_bib6","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1158\/0008-5472.CAN-09-1086","article-title":"Host-derived tumor endothelial marker 8 promotes the growth of melanoma","volume":"69","author":"Cullen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2012.01.004_bib7","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1073\/pnas.1017192108","article-title":"GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier","volume":"108","author":"Cullen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2012.01.004_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10555-007-9070-2","article-title":"Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells","volume":"26","author":"Dallas","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ccr.2012.01.004_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00000658-200212000-00002","article-title":"Liver regeneration is an angiogenesis-associated phenomenon","volume":"236","author":"Drixler","year":"2002","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ccr.2012.01.004_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1\u03b1 induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2012.01.004_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/jnci\/djm132","article-title":"Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8","volume":"99","author":"Duan","year":"2007","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccr.2012.01.004_bib12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1681\/ASN.2005080810","article-title":"Vascular endothelial growth factor A signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival","volume":"17","author":"Eremina","year":"2006","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ccr.2012.01.004_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14653240601048369","article-title":"Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag","volume":"9","author":"Felicetti","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ccr.2012.01.004_bib14","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1158\/0008-5476.CAN-09-0725","article-title":"Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice","volume":"69","author":"Fernando","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2012.01.004_bib15","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2012.01.004_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm.1877","article-title":"Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma","volume":"14","author":"Jinnin","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2012.01.004_bib17","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2012.01.004_bib18","first-page":"1399","article-title":"Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A","volume":"9","author":"Lamszus","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2012.01.004_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M707419200","article-title":"Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature","volume":"283","author":"Liu","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2012.01.004_bib20","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1073\/pnas.0905409106","article-title":"Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in\u00a0vivo","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2012.01.004_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mvr.2007.03.004","article-title":"Roles for VEGF in the adult","volume":"74","author":"Maharaj","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.ccr.2012.01.004_bib22","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood.V98.6.1904","article-title":"Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors","volume":"98","author":"Masood","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2012.01.004_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/0008-5472.CAN-03-2408","article-title":"TEM8 interacts with the cleaved C5 domain of collagen \u03b1 3(VI)","volume":"64","author":"Nanda","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2012.01.004_bib24","first-page":"7","article-title":"Improving effector functions of antibodies for cancer treatment: enhancing ADCC and CDC","volume":"3","author":"Natsume","year":"2009","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ccr.2012.01.004_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2012.01.004_bib26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/onc.2009.383","article-title":"Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis","volume":"29","author":"Reeves","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2012.01.004_bib27","first-page":"739","article-title":"The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution","volume":"32","author":"Rouleau","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccr.2012.01.004_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CJI.0b013e3181a1d134","article-title":"DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth","volume":"32","author":"Ruan","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ccr.2012.01.004_bib29","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2012.01.004_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ccr.2007.04.017","article-title":"Genes that distinguish physiological and pathological angiogenesis","volume":"11","author":"Seaman","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2012.01.004_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","article-title":"Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells","volume":"25","author":"Shojaei","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccr.2012.01.004_bib32","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium","volume":"289","author":"St. Croix","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ccr.2012.01.004_bib33","first-page":"206","article-title":"Multifaceted role of vascular endothelial growth factor signaling in adult tissue physiology: an emerging concept with clinical implications","volume":"17","author":"Sung","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ccr.2012.01.004_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc2152","article-title":"Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition","volume":"7","author":"Verheul","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2012.01.004_bib35","doi-asserted-by":"crossref","first-page":"23227","DOI":"10.1074\/jbc.M603676200","article-title":"Anthrax toxin receptor 1\/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton","volume":"281","author":"Werner","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2012.01.004_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1349-7006.2007.00402.x","article-title":"Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: association with progression and prognosis","volume":"98","author":"Yamaguchi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ccr.2012.01.004_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1586\/era.10.171","article-title":"Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer","volume":"11","author":"Yang","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ccr.2012.01.004_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbamcr.2010.11.013","article-title":"The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton","volume":"1813","author":"Yang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ccr.2012.01.004_bib39","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/j.vaccine.2010.07.014","article-title":"Dendritic cells transduced with TEM8 recombinant adenovirus prevents hepatocellular carcinoma angiogenesis and inhibits cells growth","volume":"28","author":"Yang","year":"2010","journal-title":"Vaccine"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610812000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610812000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T03:23:24Z","timestamp":1543202604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610812000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1535610812000372"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2012.01.004","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TEM8\/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2012.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}